30.01.2013 Views

2009 Annual Report - CRH

2009 Annual Report - CRH

2009 Annual Report - CRH

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

33. Related Party Transactions<br />

The principal related party relationships requiring disclosure in the Consolidated Financial Statements of the Group under<br />

IAS 24 Related Party Disclosures pertain to: the existence of subsidiaries, joint ventures and associates; transactions with<br />

these entities entered into by the Group; and the identification and compensation of key management personnel.<br />

Subsidiaries, joint ventures and associates<br />

The Consolidated Financial Statements include the financial statements of the Company (<strong>CRH</strong> plc, the ultimate parent) and<br />

its subsidiaries, joint ventures and associates as documented in the accounting policies on pages 66 to 71. The Group’s<br />

principal subsidiaries, joint ventures and associates are disclosed on pages 124 to 129.<br />

Sales to and purchases from, together with outstanding payables to and receivables from, subsidiaries and joint ventures<br />

are eliminated in the preparation of the Consolidated Financial Statements (either in full or to the extent of the Group’s<br />

interest) in accordance with IAS 27 Consolidated and Separate Financial Statements and IAS 31 Interests in Joint Ventures.<br />

The amounts in respect of joint ventures are immaterial in the context of the year-end <strong>2009</strong> financial statements. Loans<br />

extended by the Group to joint ventures and associates (see note 15) are included in financial assets (whilst the Group’s<br />

share of the corresponding loans payable by joint ventures is included in interest-bearing loans and borrowings due to the<br />

application of proportionate consolidation in accounting for the Group’s interests in these entities). Sales to and purchases<br />

from associates during the financial year ended 31st December <strong>2009</strong> amounted to €17 million (2008: €17 million) and €458<br />

million (2008: €584 million) respectively. Amounts receivable from and payable to associates (arising from the aforementioned<br />

sales and purchases transactions) as at the balance sheet date are included as separate line items in notes 18 and 19 to<br />

the Consolidated Financial Statements.<br />

Terms and conditions of transactions with subsidiaries, joint ventures and associates<br />

In general, the transfer pricing policy implemented by the Group across its subsidiaries is market-based. Sales to and<br />

purchases from other related parties (being joint ventures and associates) are conducted in the ordinary course of business<br />

and on terms equivalent to those that prevail in arm’s-length transactions. The outstanding balances included in receivables<br />

and payables as at the balance sheet date in respect of transactions with associates are unsecured and settlement arises in<br />

cash. No guarantees have been either requested or provided in relation to related party receivables and payables. Loans to<br />

joint ventures and associates (the respective amounts being disclosed in note 15) are extended on normal commercial terms<br />

in the ordinary course of business with interest accruing and, in general, paid to the Group at predetermined intervals.<br />

Key management personnel<br />

For the purposes of the disclosure requirements of IAS 24, the term “key management personnel” (i.e. those persons having<br />

authority and responsibility for planning, directing and controlling the activities of the Company) comprises the Board of<br />

Directors which manages the business and affairs of the Company. As identified in the <strong>Report</strong> on Directors’ Remuneration<br />

on pages 51 to 59, the Directors, other than the non-executive Directors, serve as executive officers of the Company. Full<br />

disclosure in relation to the <strong>2009</strong> and 2008 compensation entitlements of the Board of Directors is provided in the <strong>Report</strong><br />

on Directors’ Remuneration with disclosure of the share-based payment expense relating to the Board of Directors provided<br />

in note 7 to the Consolidated Financial Statements. Other than these compensation entitlements, there were no other<br />

transactions involving key management personnel.<br />

34. Board Approval<br />

The Board of Directors approved and authorised for issue the financial statements on pages 62 to 115 in respect of the year<br />

ended 31st December <strong>2009</strong> on 1st March 2010.<br />

<strong>CRH</strong> 115

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!